Mercator MedSystems, Inc.
2 clinical trials · 2 recruiting · INDUSTRY
Trials by Mercator MedSystems, Inc.
RECRUITINGPhase 3NCT04433572
Temsirolimus Adventitial Delivery to Improve ANGioplasty and/or Atherectomy Revascularization Outcomes Below the Knee
A multicenter, randomized, double-blind, placebo-controlled trial to evaluate the effect of Temsirolimus Perivascular Injection 0.1 mg/mL on the incidence of ischemia-driven major...
Sponsor: Mercator MedSystems, Inc.Enrolling: 2502 locations
Peripheral Artery DiseaseCritical Limb Ischemia
RECRUITINGPhase 2NCT04862468
Perivenous Dexamethasone Therapy: Examining Reduction of Inflammation After Thrombus Removal to Yield Benefit in Acute...
This is a study of a medical procedure that utilizes a commercially available catheter (the Bullfrog® Micro-Infusion Device) to locally deliver a commercially available...
Sponsor: Mercator MedSystems, Inc.Enrolling: 8017 locations
Thrombosis, Deep VeinIliofemoral; Thrombosis